Advertisement

U.S. markets open in 1 hour 45 minutes

S&P Futures
4,134.75
-7.00(-0.17%)
Dow Futures
32,790.00
-2.00(-0.01%)
Nasdaq Futures
13,123.75
-59.50(-0.45%)
Russell 2000 Futures
1,938.30
-2.80(-0.14%)
Crude Oil
91.81
+1.05(+1.16%)
Gold
1,807.90
+2.70(+0.15%)

Advertisement

Cara Therapeutics, Inc. (CARA)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD

Add to watchlist

Visitors trend2W10W9M

11.50

+0.23

(+2.04%)

At close: 04:00PM EDT

11.71

+0.21

(+1.83%)

After hours:

07:59PM EDT

Advertisement

Full screen

Trade prices are not sourced from all markets

Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies

Chart Events

Bullishpattern detected

Williams %R

View all chart patterns

Performance Outlook

Previous Close	11.27
Open	11.03
Bid	0.00 x 2200
Ask	0.00 x 1400
Day's Range	10.92 - 11.65
52 Week Range	7.40 - 18.93
Volume	622,760
Avg. Volume	576,037

Market Cap	616.299M
Beta (5Y Monthly)	1.01
PE Ratio (TTM)	N/A
EPS (TTM)	N/A
Earnings Date	N/A
Forward Dividend & Yield	N/A (N/A)
Ex-Dividend Date	N/A
1y Target Est	N/A

Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.

Fair Value

XX.XX

Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for CARA

View details

Research that delivers an independent perspective, consistent methodology and actionable insight

Related Research

Cara Therapeutics, Inc.
CARA: What does Argus have to say about CARA?CARA THERAPEUTICS INC has an Investment Rating of SELL; a target price of $7.000000; an Industry Subrating of High; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of Low.
Rating
Fair Value
Economic Moat
last monthArgus Research